Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy HOOKIPA Pharma stock | $5.02

Learn how to easily invest in HOOKIPA Pharma stock.

HOOKIPA Pharma Inc is a biotechnology business based in the US. HOOKIPA Pharma shares (HOOK) are listed on the NASDAQ and all prices are listed in US Dollars. HOOKIPA Pharma employs 109 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in HOOKIPA Pharma

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HOOK – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

HOOKIPA Pharma stock price (NASDAQ: HOOK)

Use our graph to track the performance of HOOK stocks over time.

HOOKIPA Pharma shares at a glance

Information last updated 2021-10-18.
Latest market close$5.02
52-week range$5.17 - $20.00
50-day moving average $6.18
200-day moving average $9.89
Wall St. target price$22.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.04

Buy HOOKIPA Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy HOOKIPA Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

HOOKIPA Pharma price performance over time

Historical closes compared with the close of $5.02 from 2021-10-22

1 week (2021-10-15) -6.34%
1 month (2021-09-24) -18.64%
3 months (2021-07-23) -32.44%
6 months (2021-04-23) -59.32%
1 year (2020-10-23) -47.71%
2 years (2019-10-24) -40.31%
3 years (2018-10-20) N/A
5 years (2016-10-20) N/A

HOOKIPA Pharma financials

Revenue TTM $19.9 million
Gross profit TTM $-35,203,000
Return on assets TTM -29.25%
Return on equity TTM -52.6%
Profit margin 0%
Book value $4.22
Market capitalisation $160.2 million

TTM: trailing 12 months

Shorting HOOKIPA Pharma shares

There are currently 2.2 million HOOKIPA Pharma shares held short by investors – that's known as HOOKIPA Pharma's "short interest". This figure is 9.2% down from 2.4 million last month.

There are a few different ways that this level of interest in shorting HOOKIPA Pharma shares can be evaluated.

HOOKIPA Pharma's "short interest ratio" (SIR)

HOOKIPA Pharma's "short interest ratio" (SIR) is the quantity of HOOKIPA Pharma shares currently shorted divided by the average quantity of HOOKIPA Pharma shares traded daily (recently around 252818.53546911). HOOKIPA Pharma's SIR currently stands at 8.74. In other words for every 100,000 HOOKIPA Pharma shares traded daily on the market, roughly 8740 shares are currently held short.

However HOOKIPA Pharma's short interest can also be evaluated against the total number of HOOKIPA Pharma shares, or, against the total number of tradable HOOKIPA Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HOOKIPA Pharma's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 HOOKIPA Pharma shares in existence, roughly 70 shares are currently held short) or 0.1467% of the tradable shares (for every 100,000 tradable HOOKIPA Pharma shares, roughly 147 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against HOOKIPA Pharma.

Find out more about how you can short HOOKIPA Pharma stock.

HOOKIPA Pharma share dividends

We're not expecting HOOKIPA Pharma to pay a dividend over the next 12 months.

HOOKIPA Pharma share price volatility

Over the last 12 months, HOOKIPA Pharma's shares have ranged in value from as little as $5.17 up to $20. A popular way to gauge a stock's volatility is its "beta".

HOOK.US volatility(beta: 1.15)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HOOKIPA Pharma's is 1.1533. This would suggest that HOOKIPA Pharma's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

HOOKIPA Pharma overview

HOOKIPA Pharma Inc. , a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc.

Frequently asked questions

What percentage of HOOKIPA Pharma is owned by insiders or institutions?
Currently 9.605% of HOOKIPA Pharma shares are held by insiders and 70.028% by institutions.
How many people work for HOOKIPA Pharma?
Latest data suggests 109 work at HOOKIPA Pharma.
When does the fiscal year end for HOOKIPA Pharma?
HOOKIPA Pharma's fiscal year ends in December.
Where is HOOKIPA Pharma based?
HOOKIPA Pharma's address is: 350 Fifth Avenue, New York, NY, United States, 10118
What is HOOKIPA Pharma's ISIN number?
HOOKIPA Pharma's international securities identification number is: US43906K1007
What is HOOKIPA Pharma's CUSIP number?
HOOKIPA Pharma's Committee on Uniform Securities Identification Procedures number is: 43906K100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site